A61K 31/4353
Ortho- or peri-condensed with heterocyclic ring systems
Official title: ortho- or peri-condensed with heterocyclic ring systems
A61K31/4353 (Ortho- or peri-condensed with heterocyclic ring systems) appears on 6,661 US grants and 12,935 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,661
- Published applications
- 12,935
- Assignees
- 3,705
- Inventors
- 24,091
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 17 | 0 |
| 1997 | 29 | 0 |
| 1998 | 25 | 0 |
| 1999 | 40 | 0 |
| 2000 | 33 | 0 |
| 2001 | 50 | 23 |
| 2002 | 64 | 96 |
| 2003 | 62 | 179 |
| 2004 | 59 | 213 |
| 2005 | 47 | 138 |
| 2006 | 95 | 189 |
| 2007 | 41 | 174 |
| 2008 | 52 | 232 |
| 2009 | 59 | 242 |
| 2010 | 64 | 346 |
| 2011 | 113 | 398 |
| 2012 | 148 | 373 |
| 2013 | 260 | 570 |
| 2014 | 322 | 652 |
| 2015 | 409 | 732 |
| 2016 | 462 | 791 |
| 2017 | 530 | 722 |
| 2018 | 507 | 742 |
| 2019 | 498 | 758 |
| 2020 | 485 | 757 |
| 2021 | 452 | 724 |
| 2022 | 377 | 764 |
| 2023 | 333 | 775 |
| 2024 | 387 | 839 |
| 2025 | 392 | 849 |
| 2026 | 242 | 657 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- A61K 31/437The heterocyclic ring system containing a five-membered ring having nitrogen as a3,526
- A61K 31/436The heterocyclic ring system containing a six-membered ring having oxygen as a1,613
- A61K 31/4375The heterocyclic ring system containing a six-membered ring having nitrogen as a1,247
- A61K 31/4365The heterocyclic ring system having sulfur as a ring hetero atom470
- A61K 31/4355The heterocyclic ring system containing a five-membered ring having oxygen as a297
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Oral formulations and uses thereof29 Sep 2026US 12,746,229 B2Inventisbio Co., Ltd.
- Interferon gene stimulator composition comprising indolizine derivative as active ingredient29 Sep 2026US 12,746,252 B2Ajou University Industry-Academic Cooperation Foundation
- Rapamycin-containing pharmaceutical composition22 Sep 2026US 12,740,970 B2Nobelpharma AB
- Methods for the treatment of cancers that have acquired resistance to kinase inhibitors22 Sep 2026US 12,740,979 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Glp-1r agonist and dpp-4 inhibitor compositions and methods of using8 Oct 2026US 2026/0306423 A1JDS Therapeutics, LLC
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Combination therapy for pulmonary hypertension8 Oct 2026US 2026/0306461 A1Vivus, Inc.
- Treatment of clonal hematopoietic disorders using kinase inhibitors8 Oct 2026US 2026/0306462 A1
- Sik inhibitors to treat chronic kidney disease8 Oct 2026US 2026/0306463 A1The General Hospital Corporation
Most cited
By later US patents
- Polymer compositions containing bioactive agents and methods for their use299US 6,770,729 B2Medtronic MiniMed, Inc. · 2004
- Immune response modifier compounds for treatment of TH2 mediated and related diseases285US 6,039,969 A3M Innovative Properties Company · 2000
- Coatings for medical devices285US 6,746,773 B2Ethicon, Inc. · 2004
- Formulations and methods for treatment of mucosal associated conditions with an immune response modifier272US 6,245,776 B13M Innovative Properties Company · 2001
- Method of treating restenosis with rapamycin259US 5,516,781 AAmerican Home Products Corporation · 1996